These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2568695)

  • 41. In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
    Blondin C; Hamard P; Cholley B; Haeffner-Cavaillon N; Baudouin C
    Curr Eye Res; 2003 Oct; 27(4):253-9. PubMed ID: 14562177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].
    Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632
    [No Abstract]   [Full Text] [Related]  

  • 43. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G; Randazzo S; Spina F
    Ophtalmologie; 1988; 2(5):431-3. PubMed ID: 3244464
    [No Abstract]   [Full Text] [Related]  

  • 44. Two new beta-blockers for glaucoma.
    Med Lett Drugs Ther; 1986 Apr; 28(712):45-6. PubMed ID: 2870417
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of carteolol and timolol eyedrops on the pressure tolerance of the optic nerve head].
    Stodtmeister R; Pillunat L; Wilmanns I; Neubrand M; Finger B; Tobias G
    Ophthalmologica; 1989; 198(2):64-77. PubMed ID: 2710502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changing therapy from timolol to betaxolol. Effect on intraocular pressure in selected patients with glaucoma. Timolol-Betaxolol Study Group.
    Vogel R; Tipping R; Kulaga SF; Clineschmidt CM
    Arch Ophthalmol; 1989 Sep; 107(9):1303-7. PubMed ID: 2571326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short term effects of timolol in chronic glaucoma. A double blind study using computerized perimetry.
    Holmin C; Krakau CE
    Acta Ophthalmol (Copenh); 1982 Jun; 60(3):337-46. PubMed ID: 7136544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
    Ohtake Y; Tanino T; Kimura I; Mashima Y; Oguchi Y
    Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
    Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
    Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.
    Grieshaber MC; Flammer J
    Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A clinico-pharmacological study of an ophthalmic drug form of proxodolol].
    Ermakova VN
    Eksp Klin Farmakol; 1994; 57(3):57-9. PubMed ID: 7914124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
    Pajic B; Pajic-Eggspuehler B; Häfliger IO
    Curr Med Res Opin; 2010 Sep; 26(9):2213-9. PubMed ID: 20673200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Initial experience with the beta-blocker befunolol in the treatment of open-angle glaucoma in Europe].
    Merté HJ; Stryz JR
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):55-8. PubMed ID: 6142975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of ocular drugs. 1. Timolol maleate.
    Kaufman HE
    Ophthalmology; 1980 Feb; 87(2):164-8. PubMed ID: 6104319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ; Smith SE
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trimolol: effect on intraocular pressure in chronic open-angle glaucoma.
    Obstbaum SA; Galin MA; Katz IM
    Ann Ophthalmol; 1978 Oct; 10(10):1347-51. PubMed ID: 31126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computerized perimetric monitoring and study of scotomatous fluctuations in timolol-treated open-angle glaucoma patients.
    Pecori-Giraldi J
    Surv Ophthalmol; 1989 Apr; 33 Suppl():423-5; discussion 435-6. PubMed ID: 2749511
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
    Dorigo MT; Cerin O; Fracasso G; Altafini R
    Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
    Olateju SO; Ajayi AA
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.